ClinicalThought

Share

Program Content

Activities

  • CAR-T During COVID-19
    Overcoming Challenges to CAR T-Cell Therapy During the COVID-19 Pandemic
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 31, 2021

    Expires: March 30, 2022

Faculty

cover img faculity

Caron Jacobson, MD

Associate Professor of Medicine
Harvard Medical School
Medical Director, Immune Effector Cell Therapy Program
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Kite Pharma